NEW YORK – Geneoscopy announced today that it has raised $6.9 million in a Series A financing round.
The St. Louis-based startup will use the funding to develop its colorectal cancer (CRC) screening assay, which measures eukaryotic RNA isolated from epithelial cells in stool to diagnose CRC and advanced adenomas.